Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells. (Q34655638)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

Raimondo De Cristofaro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sergio Rutella

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Maria Grazia Iachininoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Eugenia Rosa Nuzzolo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Giuseppina Bonanno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Andrea Mariotti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Annabella Procoli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Franco Locatelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

22 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

10132-10145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

8 March 2020

copyright license

start time

22 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Indoleamine 2,3 dioxygenase and metabolic control of immune responses

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Cyclooxygenases and prostaglandins: shaping up the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

The interplay between indoleamine 2,3-dioxygenase 1 (IDO1) and cyclooxygenase (COX)-2 in chronic inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

21 January 2018

Eicosanoids and cancer

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

The role of COX-2 in intestinal inflammation and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Cyclooxygenase-2 (Cox-2) and blast cells of patients with acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Mechanisms of type-I- and type-II-interferon-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

The two faces of interferon-γ in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Tolerance, not immunity, crucially depends on IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES180910132

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

21 January 2018

1 reference

12 December 2020

Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma

1 reference

12 December 2020

Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features

1 reference

12 December 2020

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

1 reference

12 December 2020

Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism

1 reference

12 December 2020

Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.

1 reference

12 December 2020

Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer

1 reference

12 December 2020

Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity

1 reference

12 December 2020

Differential regulation of a cellular gene by human interferon-gamma and interferon-alpha

1 reference

12 December 2020

Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity.

1 reference

12 December 2020

10.3390/MOLECULES180910132

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23973990%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

PubMed publication ID

23973990

1 reference